{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-089524","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2026-08-03T12:34:24+00:00","discovered_at":"2026-08-03T12:35:01.502431+00:00","generated_at":"2026-08-03T12:35:13.278440+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"low","headline":"Supernus and Indivior file investor presentation for proposed merger of equals; terms undisclosed","bullets":["Conference call held August 3, 2026 at 8:30 a.m. ET to discuss merger of equals.","Merger of equals aims to create a diversified CNS biopharmaceutical leader with significant scale.","Forward-looking statements reference a special dividend funded by additional indebtedness; amount not specified.","Indivior to file Form S-4 with joint proxy statement/prospectus for stockholder vote.","Investor presentation filed with SEC on August 3, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-089524","json":"https://secwatch.observer/filing/0001104659-26-089524.json","markdown":"https://secwatch.observer/filing/0001104659-26-089524.md","text":"https://secwatch.observer/filing/0001104659-26-089524.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000110465926089524/0001104659-26-089524-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000110465926089524/tm2622009d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T12:35:13.278440+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}